Scientists have uncovered a high-resolution molecular map of a critical blood-clotting receptor, opening the door for new treatments for cardiovascular disease, pulmonary hypertension, and inflammatory disorders.
Most Recent Articles
Genetic Risk Scores for Diabetes Subgroups as Predictors of Coronary Artery Disease
A breakthrough study shows that a person’s genetic risk for a specific diabetes subgroup can predict heart disease years before any diabetic symptoms actually appear
Impact of Fluvoxamine on Quality of Life and Fatigue Severity in Long COVID
Fluvoxamine, a common antidepressant, significantly reduces the persistent fatigue associated with long COVID, whereas the diabetes drug metformin proved ineffective.
Precision Adjuvants and the Programming of Long-Lived Mucosal T-Cell Immunity
A new study reveals that "programming" T cells with bacterial-like signals can create long-lasting lung immunity, potentially leading to respiratory vaccines that stay effective against mutations for years.
Cysteine Partitioning as a Metabolic Regulator of CD8+ T-Cell Effector Function
Breakthrough study reveals that T cells use the nutrient cysteine to balance growth and killing power, offering a new metabolic target to prevent immune exhaustion in cancer patients.